Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study.
about
The gut microbiome in human immunodeficiency virus infectionFactors Driving the HIV Epidemic in Southern Africa.MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulationEvasion of early antiviral responses by herpes simplex viruses.Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication.Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor AgonistsThe Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.Genital inflammation and the risk of HIV acquisition in womenSoluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women.Genital tract lesions in sexually mature Göttingen minipigs during the initial stages of experimental vaginal infection with Chlamydia trachomatis serovar D.HIV Incidence Among Men Who Have Sex With Men After Diagnosis With Sexually Transmitted Infections.Accurate measurement of female genital tract fluid dilution in cervicovaginal lavage samplesFc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies.Genital-Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women.BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trialHigh prevalence of asymptomatic sexually transmitted infections among human immunodeficiency virus-infected pregnant women in a low-income South African community.Effect of cytokine level variations in individuals on the progression and outcome of bacterial urogenital infections--a meta-analysis.Relationship between female genital tract infections, mucosal interleukin-17 production and local T helper type 17 cells.Inflammation and HIV Transmission in Sub-Saharan Africa.Influence of Biofilm Formation by Gardnerella vaginalis and Other Anaerobes on Bacterial Vaginosis.Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract.Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines.Preventing HIV infection without targeting the virus: how reducing HIV target cells at the genital tract is a new approach to HIV prevention.CD161 identifies polyfunctional Th1/Th17 cells in the genital mucosa that are depleted in HIV-infected female sex workers from Nairobi, Kenya.Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition.Isolation and Flow Cytometric Analysis of Human Endocervical Gamma Delta T Cells.Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology.Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota.High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study.Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.Pathogenesis of Neisseria gonorrhoeae in the female reproductive tract: neutrophilic host response, sustained infection, and clinical sequelae.Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1.Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV.Association of high-risk sexual behaviour with diversity of the vaginal microbiota and abundance of Lactobacillus.Microbial Composition Predicts Genital Tract Inflammation and Persistent Bacterial Vaginosis in South African Adolescent Females.Frequency of Human CD45+ Target Cells is a Key Determinant of Intravaginal HIV-1 Infection in Humanized Mice.Sex Differences in HIV Infection.Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women.Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women.
P2860
Q26743543-1201EA00-C23D-442E-BEA3-771290C436EAQ30387557-343ADFD1-9FE6-4710-8406-5781AC9461F4Q33390770-B353924D-5CE5-4648-81EB-781B732ABF3DQ35414669-9AB76928-FC81-4D50-830D-F065378E4CD5Q35548029-94EDAE4D-707A-47E3-8DEC-A33E6EE0FD47Q35672336-17E0C1FE-5E73-41A9-9198-E3719A1859C7Q36015881-56E61EBE-8E27-4C16-85B8-D87BF032BD05Q36017351-2CBF37CC-3C2D-4B37-8076-6D61D1BBD669Q36049017-98F06E17-A0A2-4183-864E-FFB90790CF4DQ36068677-AE227DF3-58FB-4B95-8891-AE01FAAC3D57Q36129347-34E065C4-3EBE-49B7-8099-78CB2CF21982Q36682112-D4424F4D-C34E-420A-A223-691C0DDE2E4DQ36730523-4B3D80EB-5D33-49C0-B3F1-3E36E0FAE386Q37184296-F8D13DBF-D040-4640-8A21-8E4AF9D29C13Q37639078-0BBBD016-3895-493E-929F-1CF6AD0AE899Q37730803-3AB7BE92-A560-42C7-9F50-B124A99A05B3Q37833660-51880519-509F-4860-B8E9-AA341FA3268EQ37838057-9C26A595-6E8C-4429-A216-47CDA3EE3E2AQ37839324-112ABB68-2FB8-4715-9EB7-EC827719C109Q38422546-674E3DB0-B857-421F-B3A4-D078F9633360Q38529477-71DA22A5-96B4-4383-BFE6-7D6222859ED2Q38968366-276047CE-34A6-485B-BE70-1D922F134D56Q39198905-0135C9BF-8D78-4CC1-A545-18E8088CA670Q40047164-930E02FA-3FCA-40A6-A616-255E425739A7Q40052341-7C557222-C2B5-424A-959D-9A4AEAC6D1CFQ40254597-4D54096C-A0E8-40FD-A379-2C324167879EQ40296882-1139CF0A-B30E-4500-A7CD-9722808EF202Q40332034-EC1E5E9F-0305-4718-8DBC-418764409101Q40359015-3BFD7742-9813-4A30-BFC3-A32C64F39F43Q40431590-04BA947F-1EE7-4FA8-8F16-EEA1CDCEE5B5Q40933482-53940903-1B45-42E6-B023-66CD302C129DQ45069667-3489C5BC-71B7-46D1-8CD6-B91D20BCD25CQ45812682-06AAE7B8-AB8D-44CA-8DF2-629C67737FB5Q46243938-80984638-F623-4A2C-8E2E-C077BE0B5279Q46270150-6ED49235-9102-4D1F-BB0E-7D4FF1D7EA20Q46283712-9065AAAD-79BF-403A-8B67-CF3F6589A702Q47582951-7802E351-A7B5-4162-AB42-DCD5BF59758FQ52674721-B3AB19B7-ECC9-4C2F-8431-533F1F2EEC52Q52685409-5FE841B5-9E8E-47C5-96FD-70E3080E63E2Q54988982-87AC23EE-FA36-45B0-85A7-CC2D34038201
P2860
Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 August 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Defining genital tract cytokin ...... tion: a cross-sectional study.
@en
Defining genital tract cytokin ...... tion: a cross-sectional study.
@nl
type
label
Defining genital tract cytokin ...... tion: a cross-sectional study.
@en
Defining genital tract cytokin ...... tion: a cross-sectional study.
@nl
prefLabel
Defining genital tract cytokin ...... tion: a cross-sectional study.
@en
Defining genital tract cytokin ...... tion: a cross-sectional study.
@nl
P2093
P2860
P50
P921
P1476
Defining genital tract cytokin ...... tion: a cross-sectional study.
@en
P2093
Francesca Little
Hoyam Gamieldien
Koleka Mlisana
Nonhlanhla N Mkhize
P2860
P304
P356
10.1136/SEXTRANS-2014-051601
P50
P577
2014-08-08T00:00:00Z